Showing 66,101 - 66,120 results of 101,759 for search '(( 5 ((we decrease) OR (((mean decrease) OR (a decrease)))) ) OR ( 5 point decrease ))', query time: 1.27s Refine Results
  1. 66101

    Data_Sheet_1_Peripheral Amyloid Precursor Protein Derivative Expression in Fragile X Syndrome.docx by Richard D. McLane (7337411)

    Published 2019
    “…To evaluate the viability of APP as a peripheral biological marker in FXS, we conducted an exploratory ELISA-based evaluation of plasma APP-related species involving 27 persons with FXS (mean age: 22.0 ± 11.5) and 25 age- and sex-matched persons with neurotypical development (mean age: 21.1 ± 10.7). …”
  2. 66102

    Sanger sequencing validation of chimera virus. by Hui Wang (30400)

    Published 2013
    “…(B) SNP profile of the 5’ recombination junction using the Sanger sequences, showing a decrease of polymorphism after the recombination junction. …”
  3. 66103

    DevR regulon expression in DevR<sub>C</sub>-expressing cultures declines during hypoxia. by Uma Shankar Gautam (356923)

    Published 2013
    “…The normalised intensities of the HspX-derived signals (with respect to those of SigA) are denoted as Arbitrary Signal Intensities (ASI) with respect to those obtained in 5 days hypoxic WT cultures (H5). …”
  4. 66104

    Table_2_Amentoflavone as an Ally in the Treatment of Cutaneous Leishmaniasis: Analysis of Its Antioxidant/Prooxidant Mechanisms.docx by Yasmin Silva Rizk (10195547)

    Published 2021
    “…Using BALB/c mice infected with L. amazonensis we verified the effect of an intralesional treatment with amentoflavone (0.05 mg/kg/dose, in a total of 5 doses every 4 days). …”
  5. 66105

    Table_1_Amentoflavone as an Ally in the Treatment of Cutaneous Leishmaniasis: Analysis of Its Antioxidant/Prooxidant Mechanisms.docx by Yasmin Silva Rizk (10195547)

    Published 2021
    “…Using BALB/c mice infected with L. amazonensis we verified the effect of an intralesional treatment with amentoflavone (0.05 mg/kg/dose, in a total of 5 doses every 4 days). …”
  6. 66106

    Model summarizing main findings. by K. M. Moyes (2852147)

    Published 2016
    “…This is also supported by the significant decrease in expression of negative acute phase proteins at this time (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0157480#pone.0157480.s004" target="_blank">S4 Fig</a>). …”
  7. 66107

    Table_1_Characterizing the Microbial Consortium L1 Capable of Efficiently Degrading Chlorimuron-Ethyl via Metagenome Combining 16S rDNA Sequencing.DOCX by Xiang Li (114679)

    Published 2022
    “…The consortium could degrade 98.04% of 100 mg L<sup>−1</sup> CE within 6 days. We characterized it from the samples at four time points during the degradation process and a sample without degradation activity via metagenome and 16S rDNA sequencing. …”
  8. 66108

    Table_2_Characterizing the Microbial Consortium L1 Capable of Efficiently Degrading Chlorimuron-Ethyl via Metagenome Combining 16S rDNA Sequencing.DOCX by Xiang Li (114679)

    Published 2022
    “…The consortium could degrade 98.04% of 100 mg L<sup>−1</sup> CE within 6 days. We characterized it from the samples at four time points during the degradation process and a sample without degradation activity via metagenome and 16S rDNA sequencing. …”
  9. 66109

    Image_1_Characterizing the Microbial Consortium L1 Capable of Efficiently Degrading Chlorimuron-Ethyl via Metagenome Combining 16S rDNA Sequencing.TIF by Xiang Li (114679)

    Published 2022
    “…The consortium could degrade 98.04% of 100 mg L<sup>−1</sup> CE within 6 days. We characterized it from the samples at four time points during the degradation process and a sample without degradation activity via metagenome and 16S rDNA sequencing. …”
  10. 66110

    Table_4_Characterizing the Microbial Consortium L1 Capable of Efficiently Degrading Chlorimuron-Ethyl via Metagenome Combining 16S rDNA Sequencing.XLSX by Xiang Li (114679)

    Published 2022
    “…The consortium could degrade 98.04% of 100 mg L<sup>−1</sup> CE within 6 days. We characterized it from the samples at four time points during the degradation process and a sample without degradation activity via metagenome and 16S rDNA sequencing. …”
  11. 66111

    Table_3_Characterizing the Microbial Consortium L1 Capable of Efficiently Degrading Chlorimuron-Ethyl via Metagenome Combining 16S rDNA Sequencing.XLSX by Xiang Li (114679)

    Published 2022
    “…The consortium could degrade 98.04% of 100 mg L<sup>−1</sup> CE within 6 days. We characterized it from the samples at four time points during the degradation process and a sample without degradation activity via metagenome and 16S rDNA sequencing. …”
  12. 66112

    Crested capuchin suitability change by Neander Marcel Heming (12113946)

    Published 2023
    “…Plots compare increase/decrease of suitability between the reference scenario and each of the projected scenarios for the years 2050 and 2070 and RCPs 4.5 and 8.5. …”
  13. 66113

    Visualization of Radial Peripapillary Capillaries Using Optical Coherence Tomography Angiography: The Effect of Image Averaging by Shelley Mo (3625997)

    Published 2017
    “…Quantitatively, number of endpoints decreased by 51%, and SNR, mean capillary length, capillary density, and ICD increased by 44%, 91%, 11%, and 4.5% from single frame to 10-frame averaged, respectively. …”
  14. 66114

    Changes in ambiguity and risk attitudes following the intervention. by Ruonan Jia (4731072)

    Published 2020
    “…<p>Violin and box plots of: (A) Ambiguity attitude, calculated as the difference between the choice proportion of ambiguous lotteries and the modeled choice proportion of 50% risky lotteries, before and after intervention for each group: Active Calculation, Non-active Calculation, and control. …”
  15. 66115

    H<sub>2</sub>S inhibits basolateral K<sup>+</sup> channels. by Alexandra Erb (588278)

    Published 2014
    “…<b>B</b>) The application of NaHS (1 mM) after nystatin permeabilisation resulted in a current decrease (from 47.2±5.12 µA/cm<sup>2</sup> to 36.4±2.93 µA/cm<sup>2</sup>; n = 5, N = 5, p≤0.05). …”
  16. 66116

    Differentially expressed proteins involved in coagulation and fibrinolysis. by Bin Liu (5899)

    Published 2012
    “…<p>(<b>A</b>) Annexin A5 inhibits coagulation. The coagulation activation process in this panel has been previously described in Harrison’s Principles of Internal Medicine (ref. 27 ). …”
  17. 66117

    Altered MM BM-MSC hematopoietic support and immunomodulatory capacity. by Thibaud André (392611)

    Published 2013
    “…T cell proliferation was assessed by BrdU incorporation assay after 5 days of co-culture. For each ratio, MM BM-MSCs had decreased inhibition capacity. …”
  18. 66118

    Structure contains rich information for regression. by Yuanchi Ha (18721279)

    Published 2024
    “…It shows a structured monotonically decreasing response from bottom left to top right on the full simulated landscape. …”
  19. 66119

    Supplementary Material for: Identification of risk factors associated with metabolic dysfunction-associated steatotic liver disease in psoriatic patients by Küçük K. (20178678)

    Published 2024
    “…Discussion. We identified parameters which were more prevalent in patients with psoriasis having MASLD, specifically a high BMI, elevated triglycerides levels, decreased HDL levels and an elevate level of C-peptide. …”
  20. 66120

    Bursting dynamics overview. by Mahraz Behbood (19370316)

    Published 2024
    “…For each curve from right to left (decrease in pump capacity I<sub>max</sub>): onset of bursting (inter-spike interval transitions from unimodal to bimodal), widening of the range of [K<sup>+</sup>]<sub>out</sub> covered by the oscillations, finally burst termination (via depolarization block for I<sub>app</sub> = 0.3 and 0.5 μA/cm<sup>2</sup>, or initially double period and tonic spiking before entering depolarization block for I<sub>app</sub> = 0.7 and 0.9 μA/cm<sup>2</sup>).…”